Table 3 of Abidi, Mol Vis 2011; 17:3541-3547.


Table 3. Detection rate of RB1 germline mutations in patients with retinoblastoma reported from different countries



Population

Method(s)
used
No.
of
patients


Phenotype

Global
ratea
%
in F
or SBb
%
in
SUc
%
NS/FS
mutations
%
Splicing
mutations


Reference
Japan SSCP, DHPLC, FISH 51 11 FB 4 FU
16 SB 20 SU 39 61 5 70 15 [23]
Germany SSCP, HDA, sequencing 71 B or F 72 72 ND 88 11 [24]
Spain, Colombia and Cuba Sequencing, microsatellite markers 107 11 FB 4 FU
49 SB 43 SU 50 67 20.9 58 23 [25]
China SSCP 42 14 SB 28 SU 19 50 3.6 63 37 [26]
Italy SSCP, sequencing, real-time PCR 35 7 FB 2FU
13 SB 13 SU 37 59 0 62 31 [27]
New Zeland Sequencing MLPA, FISH, bisulphite method 20 1FB 7SB 12 SU 50 100 17 60 30 [17]
Europe, North America, Asia QM-PCR, Sequencing, AS-PCR 1020 421 B 27 FU 572 SU 49 94 14.6 ND ND [19]
Switzerland DHPLC, Sequencing, STR markers 65 7 F 30 SB 28 SU 45 70 10.7 68 27 [8]
India QM-PCR RFLP, FG, Sequencing 74 53 B 4FU 17 SU 66 84 6 28.5 12.3 [16]
France DHPLC, QMPSF 192 102 B or F
90 SU 46 81.5 5.5 51 26 [14]
Mexico SSCP-Sequencing 48 21 B 27 U 19 ND ND 31 ND [28]
Argentina Sequencing 21 6 FB 7 SB 8 SU 24 80 12.5 80 0 [29]
North America Sequencing, RT, QSBA, LOH 180 85 B 10 FU 85 SU 50 88 7 ND ND [30]
Spain Sequencing, RT–PCR 43 43 SB or F 67 67 ND 69 31 [31]
Morocco Sequencing 41 1FB 1 FU
23 SB 16 SU 24 40 0 90 10 This study